Sort
21,281 grants matching “influenza”
Apollo: Increasing Access and Use of Epidemic Models Through the Development and
$524,342Michael M Wagner · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · GM
Mechanisms Of Age-related Changes in Transcriptional Regulation, TCR Repertoire, and Cytokine Expression
$523,791Nan-Ping Weng · National Institute On Aging · ZIA · FY2016 · AG
Modulation of the Immune Response to Cutaneous Immunization by S. aureus
$523,773Raif Salim Geha · National Jewish Health · U19 · FY2017 · AI
VTEU: Influenza Phase I Vaccine Clinical Trial
$523,735Wendy Keitel · Baylor College Of Medicine · N01 · FY2016 · AI
Nanoparticle Vaccine Production Core
$523,688Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies
$523,681Dusan Bogunovic · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
Dynamics of Antigen-Driven Selection in Germinal Centers
$523,550Gabriel D Victora · Rockefeller University · R01 · FY2019 · AI
Dynamics of Antigen-Driven Selection in Germinal Centers
$523,550Gabriel D Victora · Rockefeller University · R01 · FY2020 · AI
Dynamics of Antigen-Driven Selection in Germinal Centers
$523,550Gabriel D Victora · Rockefeller University · R01 · FY2017 · AI
Dynamics of Antigen-Driven Selection in Germinal Centers
$523,550Gabriel D Victora · Rockefeller University · R01 · FY2021 · AI
Dynamics of Antigen-Driven Selection in Germinal Centers
$523,550Gabriel D Victora · Rockefeller University · R01 · FY2018 · AI
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
$523,496Keven Mara Robinson · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Structural and functional analysis of the coronavirus spike protein fusion peptide
$523,463Gary R Whittaker · Cornell University · R01 · FY2019 · AI
Impact of Early-in-life Disruption of Lung Development on Adult Lung Progenitor Function
$523,424Xin Sun · University Of California, San Diego · R01 · FY2020 · HL
CVD INFLUENZA 17000: A PHASE I-II, RANDOMIZED, CONTROLLED, DOSE-RANGING STUDY
$523,254James D Campbell · University Of Maryland Baltimore · M01 · FY2007 · RR
Functional and genetic constraints on influenza virus replication and fidelity
$523,192Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
Immunization of Oral Mucosa for Induction of Rectal and Genital Mucosal Immunity
$523,120Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2010 · DE
Modeling the Coupled Dynamics of Influenza Transmission and Vaccination Behavior
$522,942Raffaele Vardavas · Rand Corporation · R01 · FY2016 · AI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis
$522,910Lisa Ann Beck · National Jewish Health · U19 · FY2015 · AI
Development of broadly-protective vaccines for influenza B viruses
$522,900Yoshihiro Kawaoka · University Of Wisconsin-Madison · R33 · FY2024 · AI
Consequences of Direct Viral-Bacterial Interactions
$522,779Jason W. Rosch · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
True Direct Single Molecule RNA Sequencing
$522,744Patrice M Milos · Helicos Bioscience Corporation · R01 · FY2011 · HG
Modulation of the Immune Response to Cutaneous Immunization by S. aureus
$522,743Raif Salim Geha · National Jewish Health · U19 · FY2019 · AI
COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants
$522,389Ousseny Zerbo · Kaiser Foundation Research Institute · R01 · FY2023 · AI
Biophysical Mechanisms of Hyperoxia-Induced Lung Injury
$522,331Christopher M Waters · University Of Kentucky · R01 · FY2023 · HL